TrimRX
US$ 27.15
natürliche glp 1 agonisten GLP-1-Rezeptor-Agonist-Marktgröße, Anteil What Are GLP-1 Agonists For
Description
May 29, 2024
Glucagon-Like Peptide 1 Analogues as Adjunctive Therapy for Patients with Type 1 Diabetes: An Updated Systematic Review and Meta-analysis
The SUSTAIN-6 trial showed reduced risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease
Mounjaro (tirzepatide) Approved - A dual-action injectable targeting GLP-1 and GIP receptors
Maclusky NJ, Cook S, Scrocchi L, Shin J, Kim J, Vaccarino F, et al
